Literature DB >> 15958463

Medical treatment of non-small-cell lung cancer.

J Buter1, G Giaccone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15958463     DOI： 10.1093/annonc/mdi721

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

1.  Genetic Modifiers of Progression-Free Survival in Never-Smoking Lung Adenocarcinoma Patients Treated with First-Line Tyrosine Kinase Inhibitors.

Authors:  I-Shou Chang; Shih Sheng Jiang; James Chih-Hsin Yang; Wu-Chou Su; Li-Hsin Chien; Chin-Fu Hsiao; Jih-Hsiang Lee; Chih-Yi Chen; Chung-Hsing Chen; Gee-Chen Chang; Zhaoming Wang; Fang-Yi Lo; Kuan-Yu Chen; Wen-Chang Wang; Yuh-Min Chen; Ming-Shyan Huang; Ying-Huang Tsai; Yu-Chun Su; Wan-Shan Hsieh; Wen-Chi Shih; Shwn-Huey Shieh; Tsung-Ying Yang; Qing Lan; Nathaniel Rothman; Chien-Jen Chen; Stephen J Chanock; Pan-Chyr Yang; Chao A Hsiung
Journal:  Am J Respir Crit Care Med       Date:  2017-03-01       Impact factor: 21.405

2.  Molecular pathways involved in the synergistic interaction of the PKC beta inhibitor enzastaurin with the antifolate pemetrexed in non-small cell lung cancer cells.

Authors:  C Tekle; E Giovannetti; J Sigmond; J R Graff; K Smid; G J Peters
Journal:  Br J Cancer       Date:  2008-08-19       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.